Efficacy of Auralgan for treating ear pain in children with acute otitis media

A. Hoberman, J. L. Paradise, E. A. Reynolds and J. Urkin
Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Pa., USA. Alejo+@pitt.edu

OBJECTIVE: To determine the efficacy of Auralgan otic solution (combination product of antipyrine, benzocaine, and glycerin) compared with an olive oil placebo in the management of moderate to severe ear pain in children with acute otitis media (AOM). DESIGN: Children 5 years or older who presented with ear pain and eardrum findings indicative of AOM were randomly assigned to treatment with Auralgan or olive oil drops instilled into the external auditory canal(s) of the affected ear(s). All children were also treated with 15 mg/kg of acetaminophen in a single dose. Ear pain was assessed by means of 2 visual analog seales-a linear scale and a color scale-at study entry and 10, 20, and 30 minutes later (T0, T10, T20, and T30, respectively). Results of the measurements on the 2 scales were evaluated independently and were averaged to determine an ear pain score. A baseline ear pain score of at least 3 points was required for study entry. Four outcome measures regarding ear pain score at T10, T20, and T30 were used: (1) proportion of subjects who showed 50% reduction, (2) proportion of subjects who showed 25% reduction, (3) proportion of subjects who showed a 1 or more point reduction, and (4) mean score over time. SETTING: Primary care center and emergency department of a children's hospital. PARTICIPANTS: Fifty-four children aged 5 to 19 years with ear pain and AOM. RESULTS: The Auralgan and placebo groups were comparable regarding age, sex, race, laterality of AOM, and T0 ear pain score. By each of the 4 measures used, the response to treatment consistently favored the Auralgan group, but only at T30 were any differences statistically significant. CONCLUSION: In children with AOM-associated ear pain who are treated with acetaminophen, topically applied Auralgan appears likely to provide additional relief in varying degree within 30 minutes.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is topical lignocaine for pain relief in acute otitis media really effective?
Bharti and Bharti
Arch. Dis. Child. 2008;93:714-714.
FULL TEXT  

A Program of Anticipatory Guidance for the Prevention of Emergency Department Visits for Ear Pain
McWilliams et al.
Arch Pediatr Adolesc Med 2008;162:151-156.
ABSTRACT | FULL TEXT  

Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial
Bolt et al.
Arch. Dis. Child. 2008;93:40-44.
ABSTRACT | FULL TEXT  

Consistency of Diagnostic Criteria for Acute Otitis Media: A Review of the Recent Literature
Chandler et al.
CLIN PEDIATR 2007;46:99-108.
ABSTRACT  

Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial.
Spiro et al.
JAMA 2006;296:1235-1241.
ABSTRACT | FULL TEXT  

Diagnosis and Management of Acute Otitis Media
Subcommittee on Management of Acute Otitis Media
Pediatrics 2004;113:1451-1465.
ABSTRACT | FULL TEXT  

Naturopathic Treatment for Ear Pain in Children
Sarrell et al.
Pediatrics 2003;111:e574-579.
ABSTRACT | FULL TEXT  

Efficacy of Naturopathic Extracts in the Management of Ear Pain Associated With Acute Otitis Media
Sarrell et al.
Arch Pediatr Adolesc Med 2001;155:796-799.
ABSTRACT | FULL TEXT  

Treating Ear Pain in Children With Acute Otitis Media
Woldman et al.
Arch Pediatr Adolesc Med 1998;152:102-102.
FULL TEXT  

Auralgan Drops for Ear Pain in AOM
JWatch Emergency Med. 1997;1997:20-20.
FULL TEXT  

AURALGAN RELIEVES EAR PAIN
JWatch General 1997;1997:3-3.
FULL TEXT